Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and Merck’s KEYTRUDA® ...

A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...

DelveInsight’s c-MET-NSCLC pipeline report depicts a robust space with 20+ active players working to develop 20+ pipeline ...

STAFFORD, Texas, Jan. 29, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical ...

DelveInsight’s, “Squamous Cell Carcinoma Pipeline Insight” report provides comprehensive insights about 75+ companies and 80+ ...

Eledon Pharmaceuticals has a promising anti-CD40L antibody for organ rejection prevention in transplantation. Learn more ...

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...

Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. Robert Kelly is managing director of XTS Energy LLC, and has ...

Global growth is projected at 3.3 percent both in 2025 and 2026, below the historical (2000–19) average of 3.7 percent. The forecast for 2025 is broadly unchanged from that in the October 2024 World ...

About Janux Therapeutics Janux is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies ... and the second targeting EGFR is being developed for colorectal ...

Confluent is a leading provider of an important technology called data streaming, which powers many real-time experiences for consumers. Confluent stock climbed to a very expensive level in 2021 ...

WEF Davos 2025: The slowdown in the Indian economy is temporary and the country will achieve 6.5% growth this fiscal, IMF Deputy Managing Director Gita Gopinath said on Tuesday. India's economic ...